A groundbreaking new analysis has uncovered evidence that Pfizer’s Covid mRNA shots may have contained bacterial DNA fragments with dangerous immune-activating signatures.
The discovery is raising urgent questions about how regulators ever allowed the injections to reach the public.
The findings were revealed in a preprint published by molecular biologist Kevin McKernan.
McKernan used advanced Oxford Nanopore sequencing technology to analyze a Pfizer vaccine lot (FL8095).
His results revealed:
Bacterial-style DNA methylation marks (m6A), a fingerprint of contamination from E. coli–derived DNA.
Evidence of incomplete linearization, meaning the DNA used to manufacture the shots may not have been fully processed, leaving behind problematic fragments.
Signals that the contamination could, in theory, trigger powerful immune responses, potentially leading to harmful side effects.
These findings raise serious questions about the integrity of the health regulatory process during the declared COVID-19 pandemic. (See link for article)
_______________
**Comment**
Science show such fragments can set off inflammation and cytokine storms.
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “aduncan@webmd.net” <aduncan@webmd.net>
Cc: “cme@medscape.net” <cme@medscape.net>, “caitlin@medlitera.com” <caitlin@medlitera.com>, “naseem@medlitera.com” <naseem@medlitera.com>, “michelle@medlitera.com” <michelle@medlitera.com>
Date: 10/28/2025 9:28 AM EDT
Subject: Re: Medscape Now! Understanding the Latest Evidence and Best Practices for Interprofessional Care of Post-Treatment Lyme Disease Syndrome
Dear Mr. Duncan,
In 2016 Dr. Paul Auwaerter, past president of the Infectious Diseases Society of America coauthored a study revealing the persister form of Borrelia burgdorferi resistant to antibiotics.
–What has tuberculosis and Borrelia burgdorferi in common? In the late stage of the disease occurs persistent (tolerant) bacteria, which essentially means that the bacteria lasts and lasts and lasts. They protect themselves against antibiotics and are difficult to treat.
–Both Borrelia burgdorferi and tuberculosis is relatively easy to cure in the early stages, even with the use of one antibiotic. In the late stage it is impossible to cure the disease with the same type of treatment in the acute phase, said Dr. Ying Zhang when he visited the year NorVect conference.
-Dr. Ying Zhang is a professor at the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health
–Two days after NorVect conference, published Dr. Ying Zhang’s latest research Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
2016
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library Jie Feng 1, Wanliang Shi 1, Shuo Zhang 1, David Sullivan 1, Paul G Auwaerter 2, Ying Zhang 1 https://pubmed.ncbi.nlm.nih.gov/27242757/
Abstract
Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia burgdorferi can develop round body forms, which are a type of persister bacteria that appear resistant in vitro to customary first-line antibiotics for Lyme disease. To identify more effective drugs with activity against the round body form of B. burgdorferi, we established a round body persister model induced by exposure to amoxicillin (50 μg/ml) and then screened the Food and Drug Administration drug library consisting of 1581 drug compounds and also 22 drug combinations using the SYBR Green I/propidium iodide viability assay. We identified 23 drug candidates that have higher activity against the round bodies of B. burgdorferi than either amoxicillin or doxycycline.
Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Despite the standard 2–4 weeks’ antibiotic treatment, approximately 10%–20% of patients will develop post treatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms that are not effectively killed by the current LD antibiotics. In this study, we evaluated nitroxoline, an antibiotic used to treat urinary tract infections, for its activity against a stationary-phase culture enriched with persister forms of B. burgdorferi. Nitroxoline was found to be more active than doxycycline and equally active as cefuroxime (standard LD antibiotics) against B. burgdorferi. Importantly, the nitroxoline two-drug combinations nitroxoline + cefuroxime and nitroxoline + clarithromycin, as well as the nitroxoline three-drug combination nitroxoline + cefuroxime + clarithromycin, were as effective as the persister drug daptomycin-based positive control three-drug combination cefuroxime + doxycycline + daptomycin, completely eradicating stationary-phase B. burgdorferi in the drug-exposure experiments and preventing regrowth in the subculture study. Future studies should evaluate these promising drug combinations in a persistent LD mouse model. Mr. Duncan…. This is the missing research that should have been conducted early in the discovery phase of the disease but as we now know, all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. What has been deceitfully established here in the US is wreaking havoc globally. Example: Lyme disease: Australians ‘being treated worse than a dog riddled with mange’, Senator John Madigan says https://www.abc.net.au/news/2016-01-11/lyme-disease-treatment-in-australia-criticised-by-john-madigan/7080708
This research is being suppressed as the disabled Lyme patient population around the globe remain sick indefinitely. (Three decades and counting)
Carl Tuttle
______________
**Comment**
We should all be eternally grateful for Lyme patient and advocate Carl Tuttle who is like a dog with a bone when it comes to relentlessly fighting for patients. His letter makes numerous salient points completely ignored by the medical machine which runs on ‘consensus’ based medicine auto-pilot, where doctors are nothing more than automatons and where AI is more likely to diagnose patients than doctors.
In part one he calls on patients to write letters to Adrian Duncan of Medscape/WebMD. The medical machine needs to hear from people who live this experience. For ideas, feel free to read the letter I wrote back in 2020 to the TBDWG which I adapted for the Medscape letter. Use your own experience and ask him to retract this harmful CME course for doctors which only entrenches the false narrative of Lyme/MSIDS.
It simply doesn’t matter that those who are ill with Lyme/MSIDS suffer with ongoing symptoms, the system tells them they are either imagining it or making it all up. The parallel universe is ruled by ‘consensus‘ based medicine where a group decides what is true or not true and then teaches doctors their decision, demands complete obedience, which omits case studies, global research, and anything that defies the consensus narrative. Then insurance companies smugly hide behind these edicts given from above so patients are forced to pay out of pocket for any true help they receive.
Further, ‘the powers that be’ are actually behind the manipulation of these pathogens in a lab to make them stronger and more infectious. No wonder they don’t want to come clean. They have a lot to answer for. Remember the Tuskagee experiment? Author Dr. Colin Ross obtained FOIA documents for this unethical government experimentation and noted that:
“The Tuskeegee Syphilis Study was eventually shut down in 1972 because of the efforts of an investigative journalist. There is no evidence to suggest that the government or the medical profession had any intention of closing the study as of 1972.”
In the video, Dr. Wodarg (pulmonologist and epidemiologist) speaks about how a false COVID ‘pandemic’ has been used for control. But COVID wasn’t his first rodeo. In the past he declared H1N1 a “false pandemic” and “one of the greatest medicine scandals of the century.” (Forbes, February 10, 2010). He is a modern day hero in my book.
Over the past few months, the phrase digital health ecosystem has crept into press releases, conference keynotes and policy documents. We are told that this new structure will make check-ups quicker, treatment cheaper and diagnostics sharper. Yet most people still wonder: What exactly is the digital health ecosystem, and why does every tech giant and government department seem to be racing to build it?
This article unpacks the concept, traces its technological building blocks and highlights the opportunities and threats hidden beneath the glossy marketing language.
Watch the presentation here:
Why new data centers are appearing everywhere
Drive through almost any U.S. state and you will notice enormous, window-less warehouses springing up like mushrooms. These facilities are not retail hubs or logistics depots—they are data centers.
Inside, thousands of servers will store and process electronic medical files, insurance records, tax information and, increasingly, the live sensor data produced by wearable gadgets. Without this storage backbone the digital health ecosystem could not exist; vast computational power is the “prerequisite,” as one IEEE paper argues, for Healthcare 4.0 to function.
A vast grab for personal data
Early in 2025, a high-profile Silicon Valley partnership DOGE obtained access to 19 sensitive U.S. Health and Human Services databases. The cache included electronic health records, IRS files, Social Security numbers, addresses and bank details—an unprecedented consolidation of personal information.
Why does this matter to the emerging digital health ecosystem? Because predictive medicine, AI-driven drug discovery and remote patient management all feed on comprehensive, real-time data. The richer the dataset, the more marketable (and profitable) the algorithms built on top of it.
The political push for wearables
Robert F. Kennedy, in his role as Secretary of Health and Human Services, openly stated that he wants “a wearable on every American within four years.” His position is echoed by similar pledges in Europe and Asia.
Wearables—smart watches, rings, patches and even earpieces—act as the edge devices of the digital health ecosystem. They harvest heart rate, temperature, blood-oxygen, movement and sleep metrics, forwarding them through body-area and personal-area networks to those sprawling data centers.
Operation Stargate and the AI pharmaceutical dream
Long before most people heard the term “generative AI,” government-funded programs such as Operation Stargate allocated more than $500 billion to AI-specific data centers. Oracle co-founder Larry Ellison boasted that the new architecture could design an mRNA vaccine “in 48 hours.”
These milestones reveal the deeper aim of the digital health ecosystem: a real-time feedback loop in which sensors feed data to the cloud, AI models simulate outcomes on “digital twins,” and automated factories print customized therapeutics on demand.
What the IEEE paper really says about Healthcare 4.0
If this article doesn’t scare the bejeebers out of you, you are asleep at the wheel.
Please read entire article in top link to educate yourself.
In short, if you believe Lyme/MSIDS is tightly controlled now, just wait for a digital health ecosystem. It will be impossible to get treatment anywhere as everything will be tyrannically monitored and controlled. The AMA and other sold out ‘professional’ organizations are already following ‘consensus’ based medicine – where decisions are made by consensus, rather than from reality, truth, or real science. Similar to how it has controlled COVID(banning effective treatments, bullying people into an experimental, never used before mRNA gene therapy, and persecuting doctors trying to save lives), it will be nearly impossible to even find an independent doctor willing to think for himself/herself.
A person in the comment section from the article stated something worth repeating here:
What stands out here is the reminder that these systems are not limited to the US, they form part of a much wider global agenda that is steadily being implemented across different countries.
This website has posted many articles on the unelected global elites and their evil plans:
BREAKING — Landmark Report Finds Vaccination Is the Dominant Risk Factor for Autism Spectrum Disorder
McCullough Foundation’s authoritative analysis of more than 300 studies provides the most comprehensive synthesis to date on the possible causes of autism.
For decades, scientists have debated what drives the relentless rise in autism. Some have claimed it’s due to “increased screening” while others declare it’s anything but vaccines. Thousands of studies have explored genetic, environmental, and perinatal factors—but very few have ever examined vaccine and non-vaccine determinants together within a unified analytical framework.
Now, the landmark McCullough Foundation Report titled, Determinants of Autism Spectrum Disorder, provides the most comprehensive synthesis on the possible causes of autism to-date. Thanks to the tireless work of Nicolas Hulscher, MPH, John S. Leake, MA, Simon Troupe, MPH, Claire Rogers, MSPAS, PA-C, Kirstin Cosgrove, BM, CCRA, M. Nathaniel Mead, MSc, PhD, Bre Craven, PA-C, Mila Radetich, Andrew Wakefield, MBBS, and Peter A. McCullough, MD, MPH — and support from the Bia-Echo Foundation — this historic effort was made possible.
Our report represents a major breakthrough through the iron grip of censorship imposed by the Bio-Pharmaceutical Complex on the issue of vaccination and autism. It also marks Dr. Andrew Wakefield’s first major return to the scientific literature in years—after enduring years of irrational attacks from the vaccine cartel.
By systematically integrating more than 300 studies across epidemiologic, clinical, mechanistic, and molecular domains, our team delivers the most extensive mapping yet of autism’s multifactorial origins and opens a new line of inquiry into how environmental and iatrogenic exposures intersect with genetic susceptibility.
By evaluating all known risk factors side by side, this analysis uniquely clarifies the relative contribution of vaccination compared to genetic and environmental domains. No prior review has attempted this integrative scope without excluding positive vaccine-association studies or unvaccinated controls—an essential step in determining whether vaccines truly play a role in autism risk, and if so, how significant that role is within the broader causal landscape.
Here’s what we found as described in the Abstract:
Introduction: Autism spectrum disorder (ASD) is now estimated to affectmore than 1 in 31 children in the United States, with prevalence rising sharply over the past two decades and posing an increasing burden to families and public health systems. Most of the literature on ASD characterizes it as a complex neurodevelopmental condition shaped by multiple determinants, including genetic liability, immune dysregulation, perinatal stressors, and environmental toxicants. Since 1996, the possible role of childhood vaccination has also been discussed and debated. This review synthesizes the full range of evidence to clarify both vaccine-related and non-vaccine contributors to ASD risk.
Methods: We comprehensively examined epidemiologic, clinical, and mechanistic studies evaluating potential ASD risk factors, assessing outcomes, exposure quantification, strength and independence of associations, temporal relationships, internal and external validity, overall cohesiveness, and biological plausibility.
Results: We found potential determinants of new onset ASD before the age of 9 years old to include: older parents (>35 years mother, >40 years father), premature delivery before 37 weeks of gestation, common genetic variants, siblings with autism, maternal immune activation, in utero drug exposure, environmental toxicants, gut-brain axis alterations and combination routine childhood vaccination. These diverse genetic, environmental, and iatrogenic factors appear to intersect through shared pathways of immune dysregulation, mitochondrial dysfunction, and neuroinflammation, culminating in neurodevelopmental injury and regression in susceptible children. Of 136 studies examining childhood vaccines or their excipients, 29 found neutral risks or no association, while 107 inferred a possible link between immunization or vaccine components and ASD or other neurodevelopmental disorders (NDDs), based on findings spanning epidemiologic, clinical, mechanistic, neuropathologic, and case-report evidence of developmental regression. 12 studies comparing routinely immunized versus completely unvaccinated children or young adults consistently demonstrated superior overall health outcomes among the unvaccinated, including significantly lower risks of chronic medical problems and neuropsychiatric disorders such as ASD. The neutral association papers were undermined by absence of a genuinely unvaccinated control group—with partial or unverified immunization even among those classified as unvaccinated—alongside registry misclassification, ecological confounding, and averaged estimates that obscure effects within vulnerable subgroups. Only a few case–control studies verified vaccination through medical records or parent-held cards, and none performed independent clinical assessments of the children for ASD. In contrast, the positive association studies found both population signals (ecologic, cohort, case–control, dose–response, and temporal clustering) and mechanistic findings converging on biologic plausibility: antigen, preservative, and adjuvant (ethyl mercury and aluminum) induced mitochondrial and neuroimmune dysfunction, central nervous system injury, and resultant incipient phenotypic expression of ASD. Clustered vaccine dosing and earlier timing of exposure during critical neurodevelopmental windows appeared to increase the risk of ASD. These findings parallel strong, consistent increases in cumulative vaccine exposure during early childhood and the reported prevalence of autism across successive birth cohorts. To date, no study has evaluated the safety of the entire cumulative pediatric vaccine schedule for neurodevelopmental outcomes through age 9 or 18 years. Nearly all existing research has focused on a narrow subset of individual vaccines or components—primarily MMR, thimerosal-containing, or aluminum-adjuvanted products—meaning that only a small fraction of total childhood vaccine exposure has ever been assessed for associations with ASD or other NDDs.
Conclusion: The totality of evidence supports a multifactorial model of ASD in which genetic predisposition, neuroimmune biology, environmental toxicants, perinatal stressors, and iatrogenic exposures converge to produce the phenotype of a post-encephalitic state. Combination and early-timed routine childhood vaccination constitutes the most significant modifiable risk factor for ASD, supported by convergent mechanistic, clinical, and epidemiologic findings, and characterized by intensified use, the clustering of multiple doses during critical neurodevelopmental windows, and the lack of research on the cumulative safety of the full pediatric schedule. As ASD prevalence continues to rise at an unprecedented pace, clarifying the risks associated with cumulative vaccine dosing and timing remains an urgent public health priority.
Madison Area Lyme Support Group 